PDR is designed to provide healthcare professionals with quick and reliable access to FDA-regulated information on over 2,400 drugs, ensuring comprehensive drug reference capabilities. This app is available for Android devices and is free for US-based medical doctors, osteopathic doctors, residents, nurse practitioners, and physician assistants. Its utility lies in the ability to access detailed drug data anytime, anywhere, enhancing the ease of use for on-the-go professionals. As a reputable source of FDA-approved information, PDR stands as a trusted and essential tool for medical practitioners seeking precise and timely drug reference.
Robust Features and Capabilities
The app delivers extensive details on prescription drugs, over-the-counter medications, and natural products, making it a versatile resource for various medical needs. PDR includes comprehensive drug label information, hundreds of full-color images, and exhaustive indexing by manufacturer, brand or generic name, and therapeutic category. Users are empowered with full prescribing details, insights into pharmacokinetics, mechanisms of action, indications, contraindications, trials data, side effects, and important warnings or precautions. This robust feature set ensures that healthcare professionals can obtain and utilize critical information efficiently to support patient care.
User-Friendly and Professional Interface
PDR has been developed in collaboration with MedHand Mobile Libraries to ensure a user-friendly, intuitive experience. Users can make notes, search through data, add bookmarks, and review past readings, allowing for a personalized workflow. The app's design prioritizes ease of navigation and speed, offering trusted medical guidelines from reputable publishers like Oxford University Press and McGraw-Hill. This emphasis on usability and credibility ensures that you can rely on PDR for accurate data when it matters most.
Requirements (Latest version)
- Android 3.0.x or higher required
Comments
There are no opinions about PDR yet. Be the first! Comment